CSL

We were honored to welcome Massachusetts Secretary of Economic Development Yvonne Hao, Undersecretary Sarah Stanton, and representatives from the Mass Life Sciences Center and MassBio to our Waltham R&D site. We are excited about the potential for further collaboration in our shared mission to enhance public health. Learn more about CSL at https://bit.ly/4fukrPt. #CSL

We recently received a positive CHMP opinion for our monoclonal antibody that targets factor Xlla to prevent hereditary angioedema attacks. We are excited about the potential this treatment offers the HAE community in addressing their needs if approved by the European Commission.

Imagine having a rare disease that few emergency room doctors know much about – and coming to the ER due to a surprise swelling attack that could be fatal. Patients who have hereditary angioedema (HAE) live with that high anxiety when they don’t get the right diagnosis or access to treatment. CSL Behring recently invited medical experts, patient advocates and members of the European Parliament to discuss how to improve HAE diagnosis and treatment in Europe. https://bit.ly/4fq9j5U #CSLBehring #CSL

We are proud to announce we have received a positive CHMP opinion for our once-monthly treatment targeting factor Xlla to prevent hereditary angioedema attacks. Read more: https://bit.ly/3ZSGmeG.

Advancing good blood health across Europe and globally is of vital importance. Today, CSL and Bristol Myers Squibb announce their partnership to continue to support the multi-stakeholder #BloodandBeyond initiative. Involving experts from hematology, transfusion medicine, patient blood management (PBM), nursing, patient advocacy, health economics, and hospital management, the multi-stakeholder initiative will continue to raise awareness of the importance of good blood health and the negative impact of anemia, and will help improve patient outcomes, including by promoting the implementation of #PBM across Europe and globally. Read more here https://bit.ly/4gwpTSz and discover more about the initiative https://bit.ly/4gtEsX9

Did you know that hemophilia A affects about 1 in 12,000 people? It’s caused by a deficiency in clotting factor VIII, which is essential for proper blood clotting. Living with hemophilia A can present unique challenges. CSL is dedicated to supporting patients and families affected by this bleeding disorder. #HemophiliaA Learn how you can support someone living with hemophilia A: https://bit.ly/4g500JZ

🌍 VIDEO: Shaping the Future, Together 🌍 Our inaugural R&D CAMP (CSL Academic Mentoring Program), co-organized by CSL and Life Science Zurich Young Scientist Network, provided valuable industry insights and career advice to life science students from diverse disciplines. At the same time, our internal mentors stepped up as leaders, refining their coaching skills and making a meaningful impact. This collaboration of minds and disciplines highlights the power of mentorship in creating a brighter future - together, we’ve built a foundation for innovation and growth! #DrivenbyOurPromise #Mentorship #FutureLeaders #LSZYSN

At CSL, we are driven by our promise to save lives and improve patient well-being around the world. We're dedicated to developing innovative therapies for rare and serious diseases, expanding access to lifesaving medicines, and always prioritizing the safety and trust of our donors and stakeholders. #HealthierCommunities Learn more about our commitment to healthier communities: https://bit.ly/4f1iU3a

At CSL, helping to protect the public’s health is a top priority. According to the U.S. Centers for Disease Control and Prevention (CDC), getting a flu vaccine each year is the best way to help prevent potentially serious flu illness from spreading through your community. This U.S. National Influenza Vaccination Week, talk to your healthcare provider about the flu vaccine that’s right for you. Learn more about what we do: https://bit.ly/3BlaTYQ #CSLSeqirus #NIVW #influenza #CDC #DrivenByOurPromise #Flu #vaccination

CSL is thrilled to announce that our Australian Graduate Program has received the 2024 Will Spensley Memorial Award for Innovation at the AGRIAs, an event hosted by the Australian Association of Graduate Employers (AAGE). This award recognises our unwavering commitment to fostering innovative thinking and providing exceptional opportunities for our graduates. We extend a special thanks to our program’s partner, Fusion Graduate Consultancy, who help drive the success of our wonderful Graduate Program. At CSL, we’re committed to Promising Futures. If you are ready to make an impact and do of work that matters, join our award-winning Graduate Program today! https://bit.ly/3B1qmNR #earlycareers #promisingfutures #innovation #AAGE #AGRIAS #graduates #interns #doworkthatmatters #csl